Semirigid ureteroscopy in management of large proximal ureteral calculi: is there still a role in developing countries?

Urology. 2011 May;77(5):1064-8. doi: 10.1016/j.urology.2010.08.067. Epub 2011 Jan 26.

Abstract

Objectives: To evaluate the outcome and complications of the use of semirigid ureteroscopy (URS) together with intracorporeal pneumatic lithotripsy in the management of upper ureteral calculi >10 mm in diameter.

Methods: A total of 75 patients (41 women and 34 men), with a mean age of 48 years (range 25-60), underwent primary URS for solitary radiopaque proximal ureteral calculi 10-20 mm in diameter (average 13.1). Dilation of the intramural ureter was done in 60 cases (80% of patients), and intracorporeal lithotripsy was required in 56 (74.6%). Ureteral catheters were left for drainage in 60% of patients, 26.7% were left unstented, and only 13.3% required an indwelling stent.

Results: Of the 75 stones, 60 (80%) were successfully cleared after a single endoscopic procedure. Our initial stone-free rate was 90.6% at 2 weeks after the primary endoscopic procedure and had reached 98.6% at 3 months. Antegrade URS for migrating stones was done successfully in 6 cases in a tubeless fashion, and open ureterolithotomy was required in 1 case. No major complications were encountered. The minor complications included only mild extravasation and self-limited postoperative fever and hematuria. The risk factors for URS failure included male gender, the severity of the hydronephrosis, the severity of impaction, and the occurrence of extravasation.

Conclusions: The results of our study have shown that semirigid URS is a safe and successful alternative to open ureterolithotomy in the management of large proximal ureteral calculi in the absence of flexible instruments.

MeSH terms

  • Adult
  • Combined Modality Therapy
  • Developing Countries
  • Egypt
  • Female
  • Humans
  • Lithotripsy
  • Male
  • Middle Aged
  • Ureteral Calculi / pathology
  • Ureteral Calculi / therapy*
  • Ureteroscopes / adverse effects
  • Ureteroscopy* / adverse effects